RI
SLS icon

Ridgewood Investments’s SELLAS Life Sciences SLS Stock Holding History

Ridgewood Investments’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$277K Hold
22,500
– – 0.1% 197
2026
Q2 		$332K Buy
+22,500
New +$155K 0.12% 179

Other funds holding SLS

EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
EM
ELCO Management New York $213M AUM 25.23% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.51B AUM 33.52% 1-Year Est. Return
FD
Financial Designs Claremont, California $194M AUM 10.52% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Ridgewood Investments's SLS Position: Q3 2026 in Review

Ridgewood Investments held its SELLAS Life Sciences (SLS) position steady in Q3 2026 at 22,500 shares worth $277K. The position accounts for 0.1% of the portfolio, ranked #197.

Ridgewood Investments first reported a position in SLS in Q2 2026 and has held it in 2 quarters since. The position peaked at $332K in Q2 2026. 12 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • Ridgewood Investments held 22,500 shares of SELLAS Life Sciences worth $277K as of Q3 2026.
  • Ridgewood Investments left its SELLAS Life Sciences share count unchanged in Q3 2026.
  • SELLAS Life Sciences made up 0.1% of Ridgewood Investments's portfolio in Q3 2026, its #197 holding.
  • Ridgewood Investments first reported a position in SELLAS Life Sciences in Q2 2026 and has held it in 2 quarters since.
  • Ridgewood Investments's SELLAS Life Sciences position peaked at $332K in Q2 2026.
  • 12 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on Ridgewood Investments's 13F filing for Q3 2026, filed 5 Oct 2026.